The FDA has granted Fast Track designation to pevifoscorvir sodium, an oral capsid assembly modulator for chronic HBV.
Oral MYC condensate modulator drives tumor regression and stasis in preclinical modelsDisruption of MYC condensates enables targeted inhibition ...
Warren Marsh's journey in and around Phoenix-City in REPLACED is a dangerous one full of hazardous obstacles and formidable ...
Expands potential opportunities for AKTX-101 and its novel RNA splicing modulator payload in additional tumors beyond current ...
Scientists are exploring prime editing to correct a genetic defect that leaves about 10% of cystic fibrosis patients without effective treatments. The technique can inscribe engineered suppressor ...
Terahertz modulation is essential for high-speed communication systems, but a long-standing trade-off between low insertion ...
Soley Therapeutics Presents Preclinical Data Demonstrating Selective Anti-Tumor Activity of STX-6398, a First-in-Class CKAP2 ...
What's the wildest random fact you know, Pandas? Have you ever heard that flour is insanely flammable, especially when ...
Tech Xplore on MSN
Silicon photonics just gained a powerful new ally, and it could reshape next-generation data links
The popularity of cloud computing and AI—driving massive data flows—pushes demand for ultra-high-speed, energy-efficient ...
A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a ...
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results